Batu Biologics Identifies Gene Types Associated with Response to ValloVax

Batu Biologics Identifies Gene Types Associated with Response to ValloVax

Preliminary Evaluation of Over 100 Patients Treated with Cancer Blood Vessel Targeting Immunotherapy Reveals Gene Association with Clinical Response

Batu Biologics announced today filing of a patent covering methods of matching cancer patients with experimental drugs under the new Right to Try Law. The recently passed law allows for companies that have passed Phase I of clinical trial to start offering terminal patients access to drugs that are still in development.

Read the full article at businesswire.com

Leave a Reply

Your email address will not be published. Required fields are marked *